STAT — Reporting from the frontiers of health and medicine
- First Opinion Support family caregivers to improve and diversify clinical trials
- First Opinion Research funding is broken. Using a lottery approach could fix it
- Health ‘Front of the line’: For Alzheimer’s patients in successful trial, a feeling of gratitude
- Health Tech STAT Plus: As AI grows in medical image analysis, concern about building trust with doctors grows too
- The Readout LOUD BU’s Covid tinkering, FDA on trial, & why it’s hard to take drugs off the market
- Pharmalot STAT Plus: Dozens of institutional investors urge drugmakers to link executive compensation to access to medicines
- Pharmalot STAT Plus: Novartis agrees to license a best-selling cancer drug to dozens of low- and middle-income countries
- First Opinion Support family caregivers to improve and diversify clinical trials
- First Opinion Research funding is broken. Using a lottery approach could fix it
- Health ‘Front of the line’: For Alzheimer’s patients in successful trial, a feeling of gratitude
- Health Tech STAT Plus: As AI grows in medical image analysis, concern about building trust with doctors grows too
- The Readout LOUD BU’s Covid tinkering, FDA on trial, & why it’s hard to take drugs off the market
- Pharmalot STAT Plus: Dozens of institutional investors urge drugmakers to link executive compensation to access to medicines
- Pharmalot STAT Plus: Novartis agrees to license a best-selling cancer drug to dozens of low- and middle-income countries
advertisement
- Exclusive STAT Plus: Inside Michelle McMurry-Heath’s departure from BIO: Firings, internal clashes, and a pivotal job review
- Insurance Medicare is going to cap patients’ spending on drugs. But there’s no such limit for hospital or doctor bills
- In the Lab Boston University researchers’ testing of lab-made version of Covid virus draws government scrutiny
-
- Health U.S. surgeon general says workplaces are taking a toll on Americans’ mental and physical health
- First Opinion Support family caregivers to improve and diversify clinical trials
- First Opinion UpToDate has a racism problem. Its name is Dr. Stanley Goldfarb
- Health ‘Front of the line’: For Alzheimer’s patients in successful trial, a feeling of gratitude
- Pharmalot STAT Plus: How one pharma insider sees the drug pricing reform law: the impact will ‘vary by product and by company’
- Health FDA’s vaccines chief sees possibility of more Covid boosters — sooner than he’d like
Reporter Spotlight
Adam is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.
Damian covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.
Usha is a national science correspondent for STAT based in Los Angeles. She is examining health inequities and their toll.
